These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9490682)

  • 1. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
    Galli M; Ruggeri L; Barbui T
    Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C.
    Galli M; Willems GM; Rosing J; Janssen RM; Govers-Riemslag JW; Comfurius P; Barbui T; Zwaal RF; Bevers EM
    Br J Haematol; 2005 Apr; 129(2):240-7. PubMed ID: 15813852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin as cofactor for antiphospholipids.
    Galli M; Barbui T
    Lupus; 1998; 7 Suppl 2():S37-40. PubMed ID: 9814670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
    Galli M; Finazzi G; Norbis F; Marziali S; Marchioli R; Barbui T
    Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles.
    Kandiah DA; Krilis SA
    Lupus; 1998; 7(5):323-32. PubMed ID: 9696136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I.
    Matsuda J; Gohchi K; Tsukamoto M; Saitoh N; Asami K; Hashimoto M
    Am J Hematol; 1993 Nov; 44(3):187-91. PubMed ID: 8213768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
    Siemens HJ; Gutsche S; Brückner S; Bucsky P; Katus HA
    Thromb Res; 2000 May; 98(4):241-7. PubMed ID: 10822070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR; Kim JE; Ha SH; Kim HK; Park S; Cho HI
    Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
    Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
    Noordermeer T; Chemlal S; Jansma JJ; van der Vegte V; Schutgens REG; Limper M; de Groot PG; Meijers JCM; Urbanus RT
    J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
    Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
    Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.